Attaching herewith a Press Release regarding grant of United States Food and Drug Administration
(USFDA) approval for the Abbreviated New Drug Application (ANDA) Cisatracurium Besylate
Injection USP to our Subsidiary Caplin Steriles Limite
| Subscribe To Our Free Newsletter |
